SQZ Biotechnologies (SQZB) Earnings Date & Reports
SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, infectious diseases, and other serious conditions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
SQZB is expected to report earnings to fall 43.12% to -45 cents per share on March 14
Q4'23
Est.
$-0.46
Q3'23
Missed
by $0.14
Q2'23
Missed
by $0.09
Q1'23
Missed
by $0.09
Q4'22
Beat
by $0.34
The last earnings report on November 08 showed earnings per share of -80 cents, missing the estimate of -65 cents. With 6.44K shares outstanding, the current market capitalization sits at 825.75K.